Table of Contents
ISRN Oncology
Volume 2012, Article ID 572342, 7 pages
http://dx.doi.org/10.5402/2012/572342
Research Article

Dose-Painted Intensity Modulated Radiation Therapy Improves Local Control for Locally Advanced Pancreas Cancer

1Department of Radiation Oncology, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, G2N45, 195 Little Albany Street, New Brunswick, NJ 08903, USA
2Department of Radiation Oncology, University of Utah School of Medicine, Huntsman Cancer Hospital, 1950 Circle of Hope, Room 1570, Salt Lake City, UT 84112, USA
3Division of Medical Oncology, Department of Medicine, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, USA
4Department of Surgery, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, USA
5Advanced Surgical Associates of New Jersey, Two Capital Way, Suite 356, Pennington, NJ 08534, USA

Received 9 August 2012; Accepted 13 September 2012

Academic Editors: R. A. Abrams and V. Lorusso

Copyright © 2012 Ahmet Tunceroglu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics,” CA—A Cancer Journal for Clinicians, vol. 62, no. 1, pp. 10–29, 2012. View at Publisher · View at Google Scholar
  2. A. Jemal, R. Siegel, E. Ward et al., “Cancer statistics, 2008,” CA—Cancer Journal for Clinicians, vol. 58, no. 2, pp. 71–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. T. Chari, “Detecting early pancreatic cancer: problems and prospects,” Seminars in Oncology, vol. 34, no. 4, pp. 284–294, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Huguet, T. André, P. Hammel et al., “Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies,” Journal of Clinical Oncology, vol. 25, no. 3, pp. 326–331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. C. Koong, E. Christofferson, Q. T. Le et al., “Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer,” International Journal of Radiation Oncology Biology Physics, vol. 63, no. 2, pp. 320–323, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Mahadevan, S. Jain, M. Goldstein et al., “Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer,” International Journal of Radiation Oncology Biology Physics, vol. 78, no. 3, pp. 735–742, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. C. A. Lacobuzio-Donahue, B. Fu, S. Yachida et al., “DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer,” Journal of Clinical Oncology, vol. 27, no. 11, pp. 1806–1813, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. H. L. Kindler, D. Niedzwiecki, D. Hollis et al., “Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303),” Journal of Clinical Oncology, vol. 28, no. 22, pp. 3617–3622, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. P. J. Loehrer Sr., Y. Feng, H. Cardenes et al., “Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial,” Journal of Clinical Oncology, vol. 29, no. 31, pp. 4105–4112.
  10. A. Y. Minn, A. Hsu, T. La et al., “Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer,” Cancer, vol. 116, no. 16, pp. 3943–3952, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. X. N. Sun, Q. Wang, B. X. Gu et al., “Adjuvant radiotherapy for gallbladder cancer: a dosimetric comparison of conformal radiotherapy and intensity-modulated radiotherapy,” World Journal of Gastroenterology, vol. 17, no. 3, pp. 397–402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Huang, J. M. Robertson, J. Margolis et al., “Long-term results of full-dose gemcitabine with radiation therapy compared to 5-fluorouracil with radiation therapy for locally advanced pancreas cancer,” Radiotherapy and Oncology, vol. 99, no. 2, pp. 114–119, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Ben-Josef, A. F. Shields, U. Vaishampayan et al., “Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer,” International Journal of Radiation Oncology Biology Physics, vol. 59, no. 2, pp. 454–459, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Rich, J. Harris, R. Abrams et al., “Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12,” American Journal of Clinical Oncology, vol. 27, no. 1, pp. 51–56, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Mawdsley, M. Hall, and R. Glynne-Jones, “Locally advanced pancreatic cancer treated with radiation and 5-fluorouracil,” Clinical Oncology, vol. 14, no. 4, pp. 308–312, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Mishra, J. Butler, C. Ho et al., “Phase II trial of induction gemcitabine/CPT-11 followed by a twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer,” American Journal of Clinical Oncology, vol. 28, no. 4, pp. 345–350, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Ben-Josef, M. Schipper, I. R. Francis et al., “A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer,” International Journal of Radiation Oncology Biology Physics. In press. View at Publisher · View at Google Scholar